MBX — Microbix Biosystems Share News
0.000.00%
Last trade - 00:00- CA$43.74m
- CA$43.30m
- CA$18.59m
Brief: Microbix Q3 Revenue Rose 17 Percent To C$3.235 Million
Brief: Microbix Biosystems Posts Q2 Revenue Of C$3.0 Million
Brief: Microbix Biosystems - Engaged Torreya Partners To Assist It With Reaching An Agreement That Enables Re-Launch Of Kinlytic Into U.S.Market
Brief: Microbix Biosystems Says Q1 Revenue Rose 48 Pct To C$2.886 Mln
Brief: Microbix Q4 Revenue Falls 19 Percent To C$2.813 Million
Brief: Microbix Biosystems Confirms Ramp-up of Production
Brief: Microbix completes second tranche of brokered private placement
Brief: Microbix announces end of legal dispute
Brief: Microbix Biosystems applies to TSX to amend terms of 1.5 mln common share purchase warrants
Brief: Microbix Biosystems Q3 revenue C$2.773 million
Brief: Microbix announces expanded customer supply agreement
Brief: Microbix announces expanded customer supply agreement
Brief: Microbix announces leadership transition
Brief: Microbix Biosystems says consulted with FDA to return its thrombolytic biologic drug to U.S. market
Brief: Microbix Q4 earnings per share $0.010
Brief: Microbix Qtrly earnings per share $0.010
Brief: Microbix Biosystems's CFO Charles Wallace to retire
Brief: Microbix appoints Jim Currie as new CFO
Brief: Microbix announces preliminary sales for 2016